nodes	percent_of_prediction	percent_of_DWPC	metapath
Nebivolol—Malnutrition—Erlotinib—pancreatic cancer	0.00437	0.00547	CcSEcCtD
Nebivolol—Bronchospasm—Gemcitabine—pancreatic cancer	0.00428	0.00536	CcSEcCtD
Nebivolol—Oedema peripheral—Sunitinib—pancreatic cancer	0.00428	0.00536	CcSEcCtD
Nebivolol—Angioedema—Tamoxifen—pancreatic cancer	0.00403	0.00505	CcSEcCtD
Nebivolol—Cardiac disorder—Sunitinib—pancreatic cancer	0.00403	0.00505	CcSEcCtD
Nebivolol—Acute coronary syndrome—Irinotecan—pancreatic cancer	0.00393	0.00492	CcSEcCtD
Nebivolol—Syncope—Erlotinib—pancreatic cancer	0.00392	0.0049	CcSEcCtD
Nebivolol—Myocardial infarction—Irinotecan—pancreatic cancer	0.00391	0.00489	CcSEcCtD
Nebivolol—Loss of consciousness—Erlotinib—pancreatic cancer	0.00384	0.0048	CcSEcCtD
Nebivolol—Acute coronary syndrome—Gemcitabine—pancreatic cancer	0.00383	0.00479	CcSEcCtD
Nebivolol—Myocardial infarction—Gemcitabine—pancreatic cancer	0.0038	0.00476	CcSEcCtD
Nebivolol—Mental disorder—Sunitinib—pancreatic cancer	0.0038	0.00476	CcSEcCtD
Nebivolol—Malnutrition—Sunitinib—pancreatic cancer	0.00378	0.00473	CcSEcCtD
Nebivolol—Acute coronary syndrome—Fluorouracil—pancreatic cancer	0.00376	0.00471	CcSEcCtD
Nebivolol—Chest pain—Tamoxifen—pancreatic cancer	0.00376	0.0047	CcSEcCtD
Nebivolol—Myocardial infarction—Fluorouracil—pancreatic cancer	0.00374	0.00468	CcSEcCtD
Nebivolol—Chest pain—Erlotinib—pancreatic cancer	0.00372	0.00465	CcSEcCtD
Nebivolol—Unspecified disorder of skin and subcutaneous tissue—Erlotinib—pancreatic cancer	0.00369	0.00462	CcSEcCtD
Nebivolol—Bradycardia—Irinotecan—pancreatic cancer	0.00364	0.00456	CcSEcCtD
Nebivolol—Thrombocytopenia—Tamoxifen—pancreatic cancer	0.00353	0.00442	CcSEcCtD
Nebivolol—Shock—Erlotinib—pancreatic cancer	0.00351	0.00439	CcSEcCtD
Nebivolol—Nervous system disorder—Erlotinib—pancreatic cancer	0.00349	0.00438	CcSEcCtD
Nebivolol—Thrombocytopenia—Erlotinib—pancreatic cancer	0.00349	0.00437	CcSEcCtD
Nebivolol—Skin disorder—Erlotinib—pancreatic cancer	0.00346	0.00433	CcSEcCtD
Nebivolol—Angioedema—Sunitinib—pancreatic cancer	0.00345	0.00432	CcSEcCtD
Nebivolol—Oedema peripheral—Gemcitabine—pancreatic cancer	0.00343	0.0043	CcSEcCtD
Nebivolol—Atrioventricular block—Epirubicin—pancreatic cancer	0.00342	0.00429	CcSEcCtD
Nebivolol—Cardiac disorder—Irinotecan—pancreatic cancer	0.00332	0.00416	CcSEcCtD
Nebivolol—Insomnia—Tamoxifen—pancreatic cancer	0.00326	0.00408	CcSEcCtD
Nebivolol—Paraesthesia—Tamoxifen—pancreatic cancer	0.00323	0.00405	CcSEcCtD
Nebivolol—Cardiac disorder—Gemcitabine—pancreatic cancer	0.00323	0.00405	CcSEcCtD
Nebivolol—Insomnia—Erlotinib—pancreatic cancer	0.00322	0.00404	CcSEcCtD
Nebivolol—Aspartate aminotransferase increased—Docetaxel—pancreatic cancer	0.00322	0.00403	CcSEcCtD
Nebivolol—Chest pain—Sunitinib—pancreatic cancer	0.00322	0.00403	CcSEcCtD
Nebivolol—Dyspnoea—Tamoxifen—pancreatic cancer	0.00321	0.00402	CcSEcCtD
Nebivolol—Unspecified disorder of skin and subcutaneous tissue—Sunitinib—pancreatic cancer	0.0032	0.004	CcSEcCtD
Nebivolol—Dyspnoea—Erlotinib—pancreatic cancer	0.00318	0.00398	CcSEcCtD
Nebivolol—Atrioventricular block—Doxorubicin—pancreatic cancer	0.00317	0.00397	CcSEcCtD
Nebivolol—Gastrointestinal disorder—Tamoxifen—pancreatic cancer	0.00311	0.00389	CcSEcCtD
Nebivolol—Fatigue—Tamoxifen—pancreatic cancer	0.00311	0.00389	CcSEcCtD
Nebivolol—Gastrointestinal disorder—Erlotinib—pancreatic cancer	0.00308	0.00385	CcSEcCtD
Nebivolol—Fatigue—Erlotinib—pancreatic cancer	0.00307	0.00385	CcSEcCtD
Nebivolol—Bronchospasm—Docetaxel—pancreatic cancer	0.00304	0.0038	CcSEcCtD
Nebivolol—Shock—Sunitinib—pancreatic cancer	0.00303	0.0038	CcSEcCtD
Nebivolol—Nervous system disorder—Sunitinib—pancreatic cancer	0.00303	0.00379	CcSEcCtD
Nebivolol—Thrombocytopenia—Sunitinib—pancreatic cancer	0.00302	0.00378	CcSEcCtD
Nebivolol—Skin disorder—Sunitinib—pancreatic cancer	0.003	0.00375	CcSEcCtD
Nebivolol—Gastrointestinal pain—Tamoxifen—pancreatic cancer	0.00295	0.00369	CcSEcCtD
Nebivolol—Gastrointestinal pain—Erlotinib—pancreatic cancer	0.00291	0.00365	CcSEcCtD
Nebivolol—Urticaria—Tamoxifen—pancreatic cancer	0.00286	0.00358	CcSEcCtD
Nebivolol—Abdominal pain—Tamoxifen—pancreatic cancer	0.00285	0.00356	CcSEcCtD
Nebivolol—Abdominal pain—Erlotinib—pancreatic cancer	0.00282	0.00353	CcSEcCtD
Nebivolol—Vertigo—Irinotecan—pancreatic cancer	0.0028	0.0035	CcSEcCtD
Nebivolol—Syncope—Irinotecan—pancreatic cancer	0.00279	0.0035	CcSEcCtD
Nebivolol—Insomnia—Sunitinib—pancreatic cancer	0.00279	0.00349	CcSEcCtD
Nebivolol—Paraesthesia—Sunitinib—pancreatic cancer	0.00277	0.00347	CcSEcCtD
Nebivolol—Dyspnoea—Sunitinib—pancreatic cancer	0.00275	0.00344	CcSEcCtD
Nebivolol—Loss of consciousness—Irinotecan—pancreatic cancer	0.00274	0.00343	CcSEcCtD
Nebivolol—Acute coronary syndrome—Docetaxel—pancreatic cancer	0.00271	0.0034	CcSEcCtD
Nebivolol—Myocardial infarction—Docetaxel—pancreatic cancer	0.0027	0.00338	CcSEcCtD
Nebivolol—Gastrointestinal disorder—Sunitinib—pancreatic cancer	0.00266	0.00333	CcSEcCtD
Nebivolol—Fatigue—Sunitinib—pancreatic cancer	0.00266	0.00333	CcSEcCtD
Nebivolol—Hypersensitivity—Tamoxifen—pancreatic cancer	0.00265	0.00332	CcSEcCtD
Nebivolol—Renal failure acute—Epirubicin—pancreatic cancer	0.00261	0.00327	CcSEcCtD
Nebivolol—Asthenia—Tamoxifen—pancreatic cancer	0.00258	0.00324	CcSEcCtD
Nebivolol—Chest pain—Gemcitabine—pancreatic cancer	0.00258	0.00323	CcSEcCtD
Nebivolol—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—pancreatic cancer	0.00256	0.00321	CcSEcCtD
Nebivolol—Asthenia—Erlotinib—pancreatic cancer	0.00256	0.0032	CcSEcCtD
Nebivolol—Pruritus—Tamoxifen—pancreatic cancer	0.00255	0.00319	CcSEcCtD
Nebivolol—Chest pain—Fluorouracil—pancreatic cancer	0.00254	0.00318	CcSEcCtD
Nebivolol—Gastrointestinal pain—Sunitinib—pancreatic cancer	0.00252	0.00316	CcSEcCtD
Nebivolol—Pruritus—Erlotinib—pancreatic cancer	0.00252	0.00316	CcSEcCtD
Nebivolol—Shock—Irinotecan—pancreatic cancer	0.0025	0.00313	CcSEcCtD
Nebivolol—Nervous system disorder—Irinotecan—pancreatic cancer	0.00249	0.00312	CcSEcCtD
Nebivolol—Thrombocytopenia—Irinotecan—pancreatic cancer	0.00249	0.00311	CcSEcCtD
Nebivolol—Diarrhoea—Tamoxifen—pancreatic cancer	0.00246	0.00309	CcSEcCtD
Nebivolol—Abdominal pain—Sunitinib—pancreatic cancer	0.00244	0.00305	CcSEcCtD
Nebivolol—Diarrhoea—Erlotinib—pancreatic cancer	0.00244	0.00305	CcSEcCtD
Nebivolol—Oedema peripheral—Docetaxel—pancreatic cancer	0.00244	0.00305	CcSEcCtD
Nebivolol—Nervous system disorder—Gemcitabine—pancreatic cancer	0.00243	0.00304	CcSEcCtD
Nebivolol—Thrombocytopenia—Gemcitabine—pancreatic cancer	0.00242	0.00303	CcSEcCtD
Nebivolol—Renal failure acute—Doxorubicin—pancreatic cancer	0.00242	0.00302	CcSEcCtD
Nebivolol—Skin disorder—Gemcitabine—pancreatic cancer	0.0024	0.00301	CcSEcCtD
Nebivolol—Nervous system disorder—Fluorouracil—pancreatic cancer	0.00239	0.00299	CcSEcCtD
Nebivolol—Thrombocytopenia—Fluorouracil—pancreatic cancer	0.00238	0.00298	CcSEcCtD
Nebivolol—Dizziness—Tamoxifen—pancreatic cancer	0.00238	0.00298	CcSEcCtD
Nebivolol—Dizziness—Erlotinib—pancreatic cancer	0.00236	0.00295	CcSEcCtD
Nebivolol—Insomnia—Irinotecan—pancreatic cancer	0.0023	0.00288	CcSEcCtD
Nebivolol—Cardiac disorder—Docetaxel—pancreatic cancer	0.00229	0.00287	CcSEcCtD
Nebivolol—Vomiting—Tamoxifen—pancreatic cancer	0.00229	0.00287	CcSEcCtD
Nebivolol—Paraesthesia—Irinotecan—pancreatic cancer	0.00228	0.00286	CcSEcCtD
Nebivolol—Hypersensitivity—Sunitinib—pancreatic cancer	0.00227	0.00285	CcSEcCtD
Nebivolol—Rash—Tamoxifen—pancreatic cancer	0.00227	0.00284	CcSEcCtD
Nebivolol—Dermatitis—Tamoxifen—pancreatic cancer	0.00227	0.00284	CcSEcCtD
Nebivolol—Vomiting—Erlotinib—pancreatic cancer	0.00227	0.00284	CcSEcCtD
Nebivolol—Dyspnoea—Irinotecan—pancreatic cancer	0.00227	0.00284	CcSEcCtD
Nebivolol—Somnolence—Irinotecan—pancreatic cancer	0.00226	0.00283	CcSEcCtD
Nebivolol—Headache—Tamoxifen—pancreatic cancer	0.00226	0.00282	CcSEcCtD
Nebivolol—Rash—Erlotinib—pancreatic cancer	0.00225	0.00281	CcSEcCtD
Nebivolol—Dermatitis—Erlotinib—pancreatic cancer	0.00224	0.00281	CcSEcCtD
Nebivolol—Insomnia—Gemcitabine—pancreatic cancer	0.00224	0.0028	CcSEcCtD
Nebivolol—Headache—Erlotinib—pancreatic cancer	0.00223	0.00279	CcSEcCtD
Nebivolol—Paraesthesia—Gemcitabine—pancreatic cancer	0.00222	0.00278	CcSEcCtD
Nebivolol—Asthenia—Sunitinib—pancreatic cancer	0.00221	0.00277	CcSEcCtD
Nebivolol—Dyspnoea—Gemcitabine—pancreatic cancer	0.00221	0.00276	CcSEcCtD
Nebivolol—Insomnia—Fluorouracil—pancreatic cancer	0.0022	0.00276	CcSEcCtD
Nebivolol—Somnolence—Gemcitabine—pancreatic cancer	0.0022	0.00275	CcSEcCtD
Nebivolol—Gastrointestinal disorder—Irinotecan—pancreatic cancer	0.00219	0.00275	CcSEcCtD
Nebivolol—Fatigue—Irinotecan—pancreatic cancer	0.00219	0.00274	CcSEcCtD
Nebivolol—Paraesthesia—Fluorouracil—pancreatic cancer	0.00219	0.00274	CcSEcCtD
Nebivolol—Pruritus—Sunitinib—pancreatic cancer	0.00218	0.00273	CcSEcCtD
Nebivolol—Aspartate aminotransferase increased—Epirubicin—pancreatic cancer	0.00217	0.00272	CcSEcCtD
Nebivolol—Dyspnoea—Fluorouracil—pancreatic cancer	0.00217	0.00272	CcSEcCtD
Nebivolol—Mental disorder—Docetaxel—pancreatic cancer	0.00217	0.00271	CcSEcCtD
Nebivolol—Somnolence—Fluorouracil—pancreatic cancer	0.00216	0.00271	CcSEcCtD
Nebivolol—Malnutrition—Docetaxel—pancreatic cancer	0.00215	0.00269	CcSEcCtD
Nebivolol—Nausea—Tamoxifen—pancreatic cancer	0.00214	0.00268	CcSEcCtD
Nebivolol—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.00214	0.00268	CcSEcCtD
Nebivolol—Fatigue—Gemcitabine—pancreatic cancer	0.00213	0.00267	CcSEcCtD
Nebivolol—Nausea—Erlotinib—pancreatic cancer	0.00212	0.00265	CcSEcCtD
Nebivolol—Diarrhoea—Sunitinib—pancreatic cancer	0.00211	0.00264	CcSEcCtD
Nebivolol—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.0021	0.00263	CcSEcCtD
Nebivolol—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.00208	0.0026	CcSEcCtD
Nebivolol—Dizziness—Sunitinib—pancreatic cancer	0.00204	0.00255	CcSEcCtD
Nebivolol—Abdominal pain—Irinotecan—pancreatic cancer	0.00201	0.00251	CcSEcCtD
Nebivolol—Aspartate aminotransferase increased—Doxorubicin—pancreatic cancer	0.00201	0.00251	CcSEcCtD
Nebivolol—Vomiting—Sunitinib—pancreatic cancer	0.00196	0.00246	CcSEcCtD
Nebivolol—Rash—Sunitinib—pancreatic cancer	0.00194	0.00244	CcSEcCtD
Nebivolol—Dermatitis—Sunitinib—pancreatic cancer	0.00194	0.00243	CcSEcCtD
Nebivolol—Urticaria—Fluorouracil—pancreatic cancer	0.00193	0.00242	CcSEcCtD
Nebivolol—Headache—Sunitinib—pancreatic cancer	0.00193	0.00242	CcSEcCtD
Nebivolol—Syncope—Docetaxel—pancreatic cancer	0.00193	0.00242	CcSEcCtD
Nebivolol—Loss of consciousness—Docetaxel—pancreatic cancer	0.00189	0.00237	CcSEcCtD
Nebivolol—Hypersensitivity—Irinotecan—pancreatic cancer	0.00187	0.00234	CcSEcCtD
Nebivolol—Chest pain—Docetaxel—pancreatic cancer	0.00183	0.00229	CcSEcCtD
Nebivolol—Nausea—Sunitinib—pancreatic cancer	0.00183	0.00229	CcSEcCtD
Nebivolol—Asthenia—Irinotecan—pancreatic cancer	0.00182	0.00228	CcSEcCtD
Nebivolol—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.00182	0.00228	CcSEcCtD
Nebivolol—Hypersensitivity—Fluorouracil—pancreatic cancer	0.00179	0.00224	CcSEcCtD
Nebivolol—Asthenia—Gemcitabine—pancreatic cancer	0.00178	0.00222	CcSEcCtD
Nebivolol—Pruritus—Gemcitabine—pancreatic cancer	0.00175	0.00219	CcSEcCtD
Nebivolol—Diarrhoea—Irinotecan—pancreatic cancer	0.00174	0.00218	CcSEcCtD
Nebivolol—Shock—Docetaxel—pancreatic cancer	0.00173	0.00216	CcSEcCtD
Nebivolol—Nervous system disorder—Docetaxel—pancreatic cancer	0.00172	0.00216	CcSEcCtD
Nebivolol—Pruritus—Fluorouracil—pancreatic cancer	0.00172	0.00216	CcSEcCtD
Nebivolol—Thrombocytopenia—Docetaxel—pancreatic cancer	0.00172	0.00215	CcSEcCtD
Nebivolol—Skin disorder—Docetaxel—pancreatic cancer	0.00171	0.00214	CcSEcCtD
Nebivolol—Bradycardia—Epirubicin—pancreatic cancer	0.0017	0.00213	CcSEcCtD
Nebivolol—Diarrhoea—Gemcitabine—pancreatic cancer	0.00169	0.00212	CcSEcCtD
Nebivolol—Dizziness—Irinotecan—pancreatic cancer	0.00168	0.0021	CcSEcCtD
Nebivolol—Diarrhoea—Fluorouracil—pancreatic cancer	0.00167	0.00208	CcSEcCtD
Nebivolol—Oedema peripheral—Epirubicin—pancreatic cancer	0.00164	0.00206	CcSEcCtD
Nebivolol—Vomiting—Irinotecan—pancreatic cancer	0.00162	0.00202	CcSEcCtD
Nebivolol—Dizziness—Fluorouracil—pancreatic cancer	0.00161	0.00201	CcSEcCtD
Nebivolol—Rash—Irinotecan—pancreatic cancer	0.0016	0.00201	CcSEcCtD
Nebivolol—Dermatitis—Irinotecan—pancreatic cancer	0.0016	0.002	CcSEcCtD
Nebivolol—Headache—Irinotecan—pancreatic cancer	0.00159	0.00199	CcSEcCtD
Nebivolol—Insomnia—Docetaxel—pancreatic cancer	0.00159	0.00199	CcSEcCtD
Nebivolol—Paraesthesia—Docetaxel—pancreatic cancer	0.00158	0.00197	CcSEcCtD
Nebivolol—Vomiting—Gemcitabine—pancreatic cancer	0.00157	0.00197	CcSEcCtD
Nebivolol—Bradycardia—Doxorubicin—pancreatic cancer	0.00157	0.00197	CcSEcCtD
Nebivolol—Dyspnoea—Docetaxel—pancreatic cancer	0.00157	0.00196	CcSEcCtD
Nebivolol—Somnolence—Docetaxel—pancreatic cancer	0.00156	0.00196	CcSEcCtD
Nebivolol—Rash—Gemcitabine—pancreatic cancer	0.00156	0.00195	CcSEcCtD
Nebivolol—Dermatitis—Gemcitabine—pancreatic cancer	0.00156	0.00195	CcSEcCtD
Nebivolol—Headache—Gemcitabine—pancreatic cancer	0.00155	0.00194	CcSEcCtD
Nebivolol—Cardiac disorder—Epirubicin—pancreatic cancer	0.00155	0.00194	CcSEcCtD
Nebivolol—Vomiting—Fluorouracil—pancreatic cancer	0.00155	0.00194	CcSEcCtD
Nebivolol—Rash—Fluorouracil—pancreatic cancer	0.00153	0.00192	CcSEcCtD
Nebivolol—Dermatitis—Fluorouracil—pancreatic cancer	0.00153	0.00192	CcSEcCtD
Nebivolol—Headache—Fluorouracil—pancreatic cancer	0.00152	0.00191	CcSEcCtD
Nebivolol—Oedema peripheral—Doxorubicin—pancreatic cancer	0.00152	0.0019	CcSEcCtD
Nebivolol—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.00152	0.0019	CcSEcCtD
Nebivolol—Fatigue—Docetaxel—pancreatic cancer	0.00151	0.0019	CcSEcCtD
Nebivolol—Nausea—Irinotecan—pancreatic cancer	0.00151	0.00189	CcSEcCtD
Nebivolol—Nausea—Gemcitabine—pancreatic cancer	0.00147	0.00184	CcSEcCtD
Nebivolol—Mental disorder—Epirubicin—pancreatic cancer	0.00146	0.00183	CcSEcCtD
Nebivolol—Malnutrition—Epirubicin—pancreatic cancer	0.00145	0.00182	CcSEcCtD
Nebivolol—Nausea—Fluorouracil—pancreatic cancer	0.00145	0.00181	CcSEcCtD
Nebivolol—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.00144	0.0018	CcSEcCtD
Nebivolol—Cardiac disorder—Doxorubicin—pancreatic cancer	0.00143	0.00179	CcSEcCtD
Nebivolol—Abdominal pain—Docetaxel—pancreatic cancer	0.00139	0.00174	CcSEcCtD
Nebivolol—Mental disorder—Doxorubicin—pancreatic cancer	0.00135	0.00169	CcSEcCtD
Nebivolol—Malnutrition—Doxorubicin—pancreatic cancer	0.00134	0.00168	CcSEcCtD
Nebivolol—Vertigo—Epirubicin—pancreatic cancer	0.0013	0.00163	CcSEcCtD
Nebivolol—Syncope—Epirubicin—pancreatic cancer	0.0013	0.00163	CcSEcCtD
Nebivolol—Hypersensitivity—Docetaxel—pancreatic cancer	0.00129	0.00162	CcSEcCtD
Nebivolol—Loss of consciousness—Epirubicin—pancreatic cancer	0.00128	0.0016	CcSEcCtD
Nebivolol—Asthenia—Docetaxel—pancreatic cancer	0.00126	0.00158	CcSEcCtD
Nebivolol—Pruritus—Docetaxel—pancreatic cancer	0.00124	0.00156	CcSEcCtD
Nebivolol—Chest pain—Epirubicin—pancreatic cancer	0.00124	0.00155	CcSEcCtD
Nebivolol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.00123	0.00154	CcSEcCtD
Nebivolol—Vertigo—Doxorubicin—pancreatic cancer	0.00121	0.00151	CcSEcCtD
Nebivolol—Syncope—Doxorubicin—pancreatic cancer	0.0012	0.00151	CcSEcCtD
Nebivolol—Diarrhoea—Docetaxel—pancreatic cancer	0.0012	0.0015	CcSEcCtD
Nebivolol—Loss of consciousness—Doxorubicin—pancreatic cancer	0.00118	0.00148	CcSEcCtD
Nebivolol—Shock—Epirubicin—pancreatic cancer	0.00117	0.00146	CcSEcCtD
Nebivolol—Nervous system disorder—Epirubicin—pancreatic cancer	0.00116	0.00145	CcSEcCtD
Nebivolol—Dizziness—Docetaxel—pancreatic cancer	0.00116	0.00145	CcSEcCtD
Nebivolol—Thrombocytopenia—Epirubicin—pancreatic cancer	0.00116	0.00145	CcSEcCtD
Nebivolol—Skin disorder—Epirubicin—pancreatic cancer	0.00115	0.00144	CcSEcCtD
Nebivolol—Chest pain—Doxorubicin—pancreatic cancer	0.00114	0.00143	CcSEcCtD
Nebivolol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.00114	0.00142	CcSEcCtD
Nebivolol—Vomiting—Docetaxel—pancreatic cancer	0.00112	0.0014	CcSEcCtD
Nebivolol—Rash—Docetaxel—pancreatic cancer	0.00111	0.00139	CcSEcCtD
Nebivolol—Dermatitis—Docetaxel—pancreatic cancer	0.00111	0.00139	CcSEcCtD
Nebivolol—Headache—Docetaxel—pancreatic cancer	0.0011	0.00138	CcSEcCtD
Nebivolol—Shock—Doxorubicin—pancreatic cancer	0.00108	0.00135	CcSEcCtD
Nebivolol—Nervous system disorder—Doxorubicin—pancreatic cancer	0.00108	0.00135	CcSEcCtD
Nebivolol—Thrombocytopenia—Doxorubicin—pancreatic cancer	0.00107	0.00134	CcSEcCtD
Nebivolol—Insomnia—Epirubicin—pancreatic cancer	0.00107	0.00134	CcSEcCtD
Nebivolol—Skin disorder—Doxorubicin—pancreatic cancer	0.00106	0.00133	CcSEcCtD
Nebivolol—Paraesthesia—Epirubicin—pancreatic cancer	0.00106	0.00133	CcSEcCtD
Nebivolol—Dyspnoea—Epirubicin—pancreatic cancer	0.00106	0.00132	CcSEcCtD
Nebivolol—Somnolence—Epirubicin—pancreatic cancer	0.00105	0.00132	CcSEcCtD
Nebivolol—Nausea—Docetaxel—pancreatic cancer	0.00104	0.00131	CcSEcCtD
Nebivolol—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.00102	0.00128	CcSEcCtD
Nebivolol—Fatigue—Epirubicin—pancreatic cancer	0.00102	0.00128	CcSEcCtD
Nebivolol—Insomnia—Doxorubicin—pancreatic cancer	0.000991	0.00124	CcSEcCtD
Nebivolol—Paraesthesia—Doxorubicin—pancreatic cancer	0.000984	0.00123	CcSEcCtD
Nebivolol—Dyspnoea—Doxorubicin—pancreatic cancer	0.000977	0.00122	CcSEcCtD
Nebivolol—Somnolence—Doxorubicin—pancreatic cancer	0.000975	0.00122	CcSEcCtD
Nebivolol—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000969	0.00121	CcSEcCtD
Nebivolol—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.000946	0.00118	CcSEcCtD
Nebivolol—Fatigue—Doxorubicin—pancreatic cancer	0.000945	0.00118	CcSEcCtD
Nebivolol—Urticaria—Epirubicin—pancreatic cancer	0.000941	0.00118	CcSEcCtD
Nebivolol—Abdominal pain—Epirubicin—pancreatic cancer	0.000937	0.00117	CcSEcCtD
Nebivolol—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.000896	0.00112	CcSEcCtD
Nebivolol—Hypersensitivity—Epirubicin—pancreatic cancer	0.000873	0.00109	CcSEcCtD
Nebivolol—Urticaria—Doxorubicin—pancreatic cancer	0.000871	0.00109	CcSEcCtD
Nebivolol—Abdominal pain—Doxorubicin—pancreatic cancer	0.000867	0.00108	CcSEcCtD
Nebivolol—Asthenia—Epirubicin—pancreatic cancer	0.00085	0.00106	CcSEcCtD
Nebivolol—Pruritus—Epirubicin—pancreatic cancer	0.000838	0.00105	CcSEcCtD
Nebivolol—Diarrhoea—Epirubicin—pancreatic cancer	0.000811	0.00101	CcSEcCtD
Nebivolol—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000808	0.00101	CcSEcCtD
Nebivolol—Asthenia—Doxorubicin—pancreatic cancer	0.000786	0.000985	CcSEcCtD
Nebivolol—Dizziness—Epirubicin—pancreatic cancer	0.000783	0.000981	CcSEcCtD
Nebivolol—Pruritus—Doxorubicin—pancreatic cancer	0.000776	0.000971	CcSEcCtD
Nebivolol—Vomiting—Epirubicin—pancreatic cancer	0.000753	0.000943	CcSEcCtD
Nebivolol—Diarrhoea—Doxorubicin—pancreatic cancer	0.00075	0.000939	CcSEcCtD
Nebivolol—Rash—Epirubicin—pancreatic cancer	0.000747	0.000935	CcSEcCtD
Nebivolol—Dermatitis—Epirubicin—pancreatic cancer	0.000746	0.000934	CcSEcCtD
Nebivolol—Headache—Epirubicin—pancreatic cancer	0.000742	0.000929	CcSEcCtD
Nebivolol—Dizziness—Doxorubicin—pancreatic cancer	0.000725	0.000908	CcSEcCtD
Nebivolol—Nausea—Epirubicin—pancreatic cancer	0.000704	0.000881	CcSEcCtD
Nebivolol—Vomiting—Doxorubicin—pancreatic cancer	0.000697	0.000873	CcSEcCtD
Nebivolol—Rash—Doxorubicin—pancreatic cancer	0.000691	0.000865	CcSEcCtD
Nebivolol—Dermatitis—Doxorubicin—pancreatic cancer	0.000691	0.000865	CcSEcCtD
Nebivolol—Headache—Doxorubicin—pancreatic cancer	0.000687	0.00086	CcSEcCtD
Nebivolol—Nausea—Doxorubicin—pancreatic cancer	0.000651	0.000815	CcSEcCtD
Nebivolol—ADRB1—Signaling by GPCR—CNR1—pancreatic cancer	0.000198	0.000984	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—DTX4—pancreatic cancer	0.000198	0.000983	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—GLI1—pancreatic cancer	0.000198	0.000983	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—PPP2R5B—pancreatic cancer	0.000197	0.000977	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—NRP1—pancreatic cancer	0.000197	0.000977	CbGpPWpGaD
Nebivolol—ADRB2—GPCR downstream signaling—AGTR1—pancreatic cancer	0.000197	0.000976	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—CNR1—pancreatic cancer	0.000194	0.000962	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—DTX4—pancreatic cancer	0.000193	0.000961	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—GLI1—pancreatic cancer	0.000193	0.000961	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—NRP1—pancreatic cancer	0.000192	0.000956	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—PPP2R5B—pancreatic cancer	0.000192	0.000956	CbGpPWpGaD
Nebivolol—HTR1A—GPCR downstream signaling—AGTR1—pancreatic cancer	0.000192	0.000955	CbGpPWpGaD
Nebivolol—ADRB1—Signaling by GPCR—GCG—pancreatic cancer	0.000191	0.00095	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—CNR1—pancreatic cancer	0.000189	0.000941	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—HEY2—pancreatic cancer	0.000189	0.000941	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—NRP1—pancreatic cancer	0.000188	0.000935	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—PPP2R5B—pancreatic cancer	0.000188	0.000935	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—GCG—pancreatic cancer	0.000187	0.000929	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—HEY2—pancreatic cancer	0.000185	0.00092	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—GAST—pancreatic cancer	0.000185	0.000919	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—GCG—pancreatic cancer	0.000183	0.000909	CbGpPWpGaD
Nebivolol—ADRB1—Signaling by GPCR—AGTR1—pancreatic cancer	0.000182	0.000906	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—HEY2—pancreatic cancer	0.000181	0.0009	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—GAST—pancreatic cancer	0.000181	0.000899	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—AGTR1—pancreatic cancer	0.000179	0.000887	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—GAST—pancreatic cancer	0.000177	0.000879	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—SCT—pancreatic cancer	0.000175	0.000871	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—HEY1—pancreatic cancer	0.000175	0.000871	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—AGTR1—pancreatic cancer	0.000175	0.000867	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—SCT—pancreatic cancer	0.000172	0.000852	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—HEY1—pancreatic cancer	0.000172	0.000852	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—SCT—pancreatic cancer	0.000168	0.000833	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—HEY1—pancreatic cancer	0.000168	0.000833	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—CCK—pancreatic cancer	0.000167	0.000831	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—CCK—pancreatic cancer	0.000164	0.000813	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—CNR2—pancreatic cancer	0.000163	0.00081	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—GLP1R—pancreatic cancer	0.000163	0.00081	CbGpPWpGaD
Nebivolol—ADRB1—GPCR ligand binding—CXCL8—pancreatic cancer	0.000163	0.000809	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—CCKAR—pancreatic cancer	0.00016	0.000797	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—CCK—pancreatic cancer	0.00016	0.000795	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—CNR2—pancreatic cancer	0.000159	0.000792	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—GLP1R—pancreatic cancer	0.000159	0.000792	CbGpPWpGaD
Nebivolol—ADRB2—GPCR ligand binding—CXCL8—pancreatic cancer	0.000159	0.000792	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—CCKAR—pancreatic cancer	0.000157	0.000779	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—PRSS1—pancreatic cancer	0.000156	0.000777	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—CNR2—pancreatic cancer	0.000156	0.000775	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—GLP1R—pancreatic cancer	0.000156	0.000775	CbGpPWpGaD
Nebivolol—HTR1A—GPCR ligand binding—CXCL8—pancreatic cancer	0.000156	0.000774	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—JAG2—pancreatic cancer	0.000156	0.000773	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—CCKAR—pancreatic cancer	0.000153	0.000762	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—MEN1—pancreatic cancer	0.000153	0.000761	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—JAG2—pancreatic cancer	0.000152	0.000756	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—MEN1—pancreatic cancer	0.00015	0.000745	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—JAG2—pancreatic cancer	0.000149	0.000739	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—MEN1—pancreatic cancer	0.000147	0.000728	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—SHH—pancreatic cancer	0.000146	0.000726	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—NOTCH4—pancreatic cancer	0.000145	0.000722	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—IAPP—pancreatic cancer	0.000144	0.000717	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—SHH—pancreatic cancer	0.000143	0.000711	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—NOTCH4—pancreatic cancer	0.000142	0.000706	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—IAPP—pancreatic cancer	0.000141	0.000702	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—SHH—pancreatic cancer	0.00014	0.000695	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—NOTCH4—pancreatic cancer	0.000139	0.00069	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—PTCH1—pancreatic cancer	0.000139	0.000689	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—PTHLH—pancreatic cancer	0.000139	0.000689	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—IAPP—pancreatic cancer	0.000138	0.000686	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—PTHLH—pancreatic cancer	0.000136	0.000674	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—PTCH1—pancreatic cancer	0.000136	0.000674	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—ARG2—pancreatic cancer	0.000136	0.000673	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—PTHLH—pancreatic cancer	0.000133	0.000659	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—PTCH1—pancreatic cancer	0.000133	0.000659	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—SST—pancreatic cancer	0.000127	0.00063	CbGpPWpGaD
Nebivolol—ADRB1—GPCR downstream signaling—PIK3CG—pancreatic cancer	0.000125	0.000621	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—JAG1—pancreatic cancer	0.000124	0.000616	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—SST—pancreatic cancer	0.000124	0.000616	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—NOTCH3—pancreatic cancer	0.000124	0.000614	CbGpPWpGaD
Nebivolol—ADRB2—GPCR downstream signaling—PIK3CG—pancreatic cancer	0.000122	0.000608	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—JAG1—pancreatic cancer	0.000121	0.000603	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—SST—pancreatic cancer	0.000121	0.000602	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—NOTCH3—pancreatic cancer	0.000121	0.0006	CbGpPWpGaD
Nebivolol—HTR1A—GPCR downstream signaling—PIK3CG—pancreatic cancer	0.00012	0.000594	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—JAG1—pancreatic cancer	0.000119	0.000589	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—TYMP—pancreatic cancer	0.000118	0.000589	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—NOTCH3—pancreatic cancer	0.000118	0.000587	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—CNR1—pancreatic cancer	0.000117	0.000581	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—CNR1—pancreatic cancer	0.000114	0.000569	CbGpPWpGaD
Nebivolol—ADRB1—Signaling by GPCR—PIK3CG—pancreatic cancer	0.000114	0.000564	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—GCG—pancreatic cancer	0.000113	0.000561	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—CNR1—pancreatic cancer	0.000112	0.000556	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—PIK3CG—pancreatic cancer	0.000111	0.000552	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—GCG—pancreatic cancer	0.000111	0.000549	CbGpPWpGaD
Nebivolol—ADRB1—GPCR downstream signaling—PIK3CD—pancreatic cancer	0.00011	0.000546	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—PIK3CG—pancreatic cancer	0.000109	0.00054	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—GCG—pancreatic cancer	0.000108	0.000537	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—AGTR1—pancreatic cancer	0.000108	0.000535	CbGpPWpGaD
Nebivolol—ADRB2—GPCR downstream signaling—PIK3CD—pancreatic cancer	0.000108	0.000534	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—STK11—pancreatic cancer	0.000106	0.000528	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—AGTR1—pancreatic cancer	0.000105	0.000524	CbGpPWpGaD
Nebivolol—HTR1A—GPCR downstream signaling—PIK3CD—pancreatic cancer	0.000105	0.000522	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—STK11—pancreatic cancer	0.000104	0.000516	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—AGTR1—pancreatic cancer	0.000103	0.000512	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—STK11—pancreatic cancer	0.000102	0.000505	CbGpPWpGaD
Nebivolol—ADRB1—Signaling by GPCR—PIK3CD—pancreatic cancer	9.98e-05	0.000496	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—PIK3CD—pancreatic cancer	9.76e-05	0.000485	CbGpPWpGaD
Nebivolol—ADRB1—GPCR downstream signaling—PIK3CB—pancreatic cancer	9.58e-05	0.000476	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—GLP1R—pancreatic cancer	9.55e-05	0.000474	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—PIK3CD—pancreatic cancer	9.55e-05	0.000474	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—DPYD—pancreatic cancer	9.4e-05	0.000467	CbGpPWpGaD
Nebivolol—ADRB2—GPCR downstream signaling—PIK3CB—pancreatic cancer	9.37e-05	0.000466	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—SMAD4—pancreatic cancer	9.31e-05	0.000462	CbGpPWpGaD
Nebivolol—ADRB1—GPCR downstream signaling—CXCL8—pancreatic cancer	9.21e-05	0.000457	CbGpPWpGaD
Nebivolol—HTR1A—GPCR downstream signaling—PIK3CB—pancreatic cancer	9.16e-05	0.000455	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—SMAD4—pancreatic cancer	9.1e-05	0.000452	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—HES1—pancreatic cancer	9.09e-05	0.000451	CbGpPWpGaD
Nebivolol—ADRB2—GPCR downstream signaling—CXCL8—pancreatic cancer	9.01e-05	0.000447	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—SLC2A2—pancreatic cancer	8.92e-05	0.000443	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—SMAD4—pancreatic cancer	8.9e-05	0.000442	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—HES1—pancreatic cancer	8.89e-05	0.000441	CbGpPWpGaD
Nebivolol—HTR1A—GPCR downstream signaling—CXCL8—pancreatic cancer	8.81e-05	0.000437	CbGpPWpGaD
Nebivolol—ADRB1—Signaling by GPCR—PIK3CB—pancreatic cancer	8.7e-05	0.000432	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—HES1—pancreatic cancer	8.69e-05	0.000432	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—PIK3CB—pancreatic cancer	8.51e-05	0.000423	CbGpPWpGaD
Nebivolol—ADRB1—Signaling by GPCR—CXCL8—pancreatic cancer	8.36e-05	0.000415	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—PIK3CB—pancreatic cancer	8.32e-05	0.000413	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—CXCL8—pancreatic cancer	8.18e-05	0.000406	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—CXCL8—pancreatic cancer	8e-05	0.000397	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—TERT—pancreatic cancer	7.96e-05	0.000395	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—TERT—pancreatic cancer	7.79e-05	0.000387	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—TERT—pancreatic cancer	7.62e-05	0.000378	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—HIF1A—pancreatic cancer	7.61e-05	0.000378	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—TSC2—pancreatic cancer	7.59e-05	0.000377	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—HIF1A—pancreatic cancer	7.45e-05	0.00037	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—APOE—pancreatic cancer	7.43e-05	0.000369	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—TSC2—pancreatic cancer	7.43e-05	0.000369	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—HIF1A—pancreatic cancer	7.28e-05	0.000362	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—KDR—pancreatic cancer	7.28e-05	0.000362	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—APOE—pancreatic cancer	7.27e-05	0.000361	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—TSC2—pancreatic cancer	7.26e-05	0.000361	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—KDR—pancreatic cancer	7.12e-05	0.000354	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—APOE—pancreatic cancer	7.11e-05	0.000353	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—KDR—pancreatic cancer	6.96e-05	0.000346	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—NFKBIA—pancreatic cancer	6.93e-05	0.000344	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—CD44—pancreatic cancer	6.91e-05	0.000343	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—NOTCH1—pancreatic cancer	6.86e-05	0.000341	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—NFKBIA—pancreatic cancer	6.78e-05	0.000337	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—NOTCH1—pancreatic cancer	6.71e-05	0.000333	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—PIK3CG—pancreatic cancer	6.71e-05	0.000333	CbGpPWpGaD
Nebivolol—ADRB1—Signaling by GPCR—NRAS—pancreatic cancer	6.71e-05	0.000333	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—EGF—pancreatic cancer	6.63e-05	0.000329	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—NFKBIA—pancreatic cancer	6.62e-05	0.000329	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—GCG—pancreatic cancer	6.62e-05	0.000329	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—PIK3CG—pancreatic cancer	6.56e-05	0.000326	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—NRAS—pancreatic cancer	6.56e-05	0.000326	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—NOTCH1—pancreatic cancer	6.56e-05	0.000326	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—EGF—pancreatic cancer	6.49e-05	0.000322	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—PIK3CG—pancreatic cancer	6.42e-05	0.000319	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—NRAS—pancreatic cancer	6.42e-05	0.000319	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—EGF—pancreatic cancer	6.34e-05	0.000315	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—STK11—pancreatic cancer	6.22e-05	0.000309	CbGpPWpGaD
Nebivolol—ADRB1—Signaling by GPCR—EGFR—pancreatic cancer	6.11e-05	0.000304	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—EGFR—pancreatic cancer	5.98e-05	0.000297	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—PIK3CD—pancreatic cancer	5.9e-05	0.000293	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—EGFR—pancreatic cancer	5.85e-05	0.00029	CbGpPWpGaD
Nebivolol—ADRB1—GPCR downstream signaling—PIK3CA—pancreatic cancer	5.84e-05	0.00029	CbGpPWpGaD
Nebivolol—ADRB1—Signaling by GPCR—KRAS—pancreatic cancer	5.77e-05	0.000287	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—PIK3CD—pancreatic cancer	5.77e-05	0.000287	CbGpPWpGaD
Nebivolol—ADRB2—GPCR downstream signaling—PIK3CA—pancreatic cancer	5.71e-05	0.000284	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—KRAS—pancreatic cancer	5.65e-05	0.000281	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—PIK3CD—pancreatic cancer	5.64e-05	0.00028	CbGpPWpGaD
Nebivolol—HTR1A—GPCR downstream signaling—PIK3CA—pancreatic cancer	5.59e-05	0.000278	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—KRAS—pancreatic cancer	5.52e-05	0.000274	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—TYMS—pancreatic cancer	5.35e-05	0.000266	CbGpPWpGaD
Nebivolol—ADRB1—Signaling by GPCR—PIK3CA—pancreatic cancer	5.3e-05	0.000263	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—PIK3CA—pancreatic cancer	5.19e-05	0.000258	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—PIK3CB—pancreatic cancer	5.14e-05	0.000255	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—PIK3CA—pancreatic cancer	5.07e-05	0.000252	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—PIK3CB—pancreatic cancer	5.03e-05	0.00025	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—CXCL8—pancreatic cancer	4.94e-05	0.000245	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—PIK3CB—pancreatic cancer	4.92e-05	0.000244	CbGpPWpGaD
Nebivolol—ADRB1—Signaling by GPCR—HRAS—pancreatic cancer	4.91e-05	0.000244	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—CXCL8—pancreatic cancer	4.83e-05	0.00024	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—HRAS—pancreatic cancer	4.8e-05	0.000238	CbGpPWpGaD
Nebivolol—ADRB1—GPCR downstream signaling—AKT1—pancreatic cancer	4.77e-05	0.000237	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—CASP3—pancreatic cancer	4.73e-05	0.000235	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—CXCL8—pancreatic cancer	4.72e-05	0.000235	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—HRAS—pancreatic cancer	4.69e-05	0.000233	CbGpPWpGaD
Nebivolol—ADRB2—GPCR downstream signaling—AKT1—pancreatic cancer	4.67e-05	0.000232	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—CASP3—pancreatic cancer	4.62e-05	0.00023	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—CCND1—pancreatic cancer	4.6e-05	0.000229	CbGpPWpGaD
Nebivolol—HTR1A—GPCR downstream signaling—AKT1—pancreatic cancer	4.56e-05	0.000227	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—CTNNB1—pancreatic cancer	4.56e-05	0.000226	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—CASP3—pancreatic cancer	4.52e-05	0.000225	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—CCND1—pancreatic cancer	4.5e-05	0.000224	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—MMP9—pancreatic cancer	4.47e-05	0.000222	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—CTNNB1—pancreatic cancer	4.46e-05	0.000221	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—PTEN—pancreatic cancer	4.44e-05	0.000221	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—CCND1—pancreatic cancer	4.4e-05	0.000219	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—MMP9—pancreatic cancer	4.37e-05	0.000217	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—CTNNB1—pancreatic cancer	4.36e-05	0.000217	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—APOE—pancreatic cancer	4.35e-05	0.000216	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—PTEN—pancreatic cancer	4.34e-05	0.000216	CbGpPWpGaD
Nebivolol—ADRB1—Signaling by GPCR—AKT1—pancreatic cancer	4.33e-05	0.000215	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—MMP9—pancreatic cancer	4.27e-05	0.000212	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—PTEN—pancreatic cancer	4.25e-05	0.000211	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—AKT1—pancreatic cancer	4.24e-05	0.000211	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—AKT1—pancreatic cancer	4.14e-05	0.000206	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—SRC—pancreatic cancer	4.12e-05	0.000205	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—SRC—pancreatic cancer	4.03e-05	0.0002	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—VEGFA—pancreatic cancer	4.01e-05	0.000199	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—STAT3—pancreatic cancer	3.97e-05	0.000197	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—NRAS—pancreatic cancer	3.96e-05	0.000197	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—SRC—pancreatic cancer	3.94e-05	0.000196	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—PIK3CG—pancreatic cancer	3.93e-05	0.000195	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—VEGFA—pancreatic cancer	3.92e-05	0.000195	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—STAT3—pancreatic cancer	3.89e-05	0.000193	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—NRAS—pancreatic cancer	3.88e-05	0.000193	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—VEGFA—pancreatic cancer	3.84e-05	0.000191	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—STAT3—pancreatic cancer	3.8e-05	0.000189	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—PPARG—pancreatic cancer	3.79e-05	0.000188	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—NRAS—pancreatic cancer	3.79e-05	0.000188	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—MYC—pancreatic cancer	3.69e-05	0.000183	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—TGFB1—pancreatic cancer	3.68e-05	0.000183	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—MYC—pancreatic cancer	3.61e-05	0.000179	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—EGFR—pancreatic cancer	3.61e-05	0.000179	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—TGFB1—pancreatic cancer	3.6e-05	0.000179	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—EGFR—pancreatic cancer	3.53e-05	0.000175	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—MYC—pancreatic cancer	3.53e-05	0.000175	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—TGFB1—pancreatic cancer	3.52e-05	0.000175	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—PIK3CD—pancreatic cancer	3.45e-05	0.000172	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—EGFR—pancreatic cancer	3.45e-05	0.000172	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—KRAS—pancreatic cancer	3.41e-05	0.000169	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—KRAS—pancreatic cancer	3.34e-05	0.000166	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—KRAS—pancreatic cancer	3.26e-05	0.000162	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—PIK3CA—pancreatic cancer	3.13e-05	0.000156	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—PIK3CA—pancreatic cancer	3.06e-05	0.000152	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—TP53—pancreatic cancer	3.03e-05	0.000151	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—PIK3CB—pancreatic cancer	3.01e-05	0.00015	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—PIK3CA—pancreatic cancer	3e-05	0.000149	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—PTGS2—pancreatic cancer	2.98e-05	0.000148	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—TP53—pancreatic cancer	2.97e-05	0.000147	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—TP53—pancreatic cancer	2.9e-05	0.000144	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—HRAS—pancreatic cancer	2.9e-05	0.000144	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—HRAS—pancreatic cancer	2.84e-05	0.000141	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—HRAS—pancreatic cancer	2.77e-05	0.000138	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—PTEN—pancreatic cancer	2.6e-05	0.000129	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—AKT1—pancreatic cancer	2.56e-05	0.000127	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—AKT1—pancreatic cancer	2.5e-05	0.000124	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—AKT1—pancreatic cancer	2.45e-05	0.000122	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—PIK3CA—pancreatic cancer	1.84e-05	9.12e-05	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—AKT1—pancreatic cancer	1.5e-05	7.45e-05	CbGpPWpGaD
